Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Electron Gives Partners Proteomics Center Four New LC/MS Systems

NEW YORK, Oct. 18-Thermo Electron and Partners HealthCare will officially announce an instrumentation research partnership at a symposium today celebrating Partners' new proteomics center.


The high-tech equipment company has donated four Thermo Finnegan ProteomeX liquid chromatography mass spectrometry systems to the proteomics wing of the Harvard-Partners Center for Genetics and Genomics. A Thermo proteomics application specialist will also be in residence at the new center to provide support for the systems and provide feedback to the company.


"It seemed like a good opportunity for both of us," said Thermo Electron spokesperson Caroline Grossman. "He will be a support to them in terms of helping them figure out the best ways to run the experiments they want to. From our point of view, we're always looking to develop tools that researchers really want to use."


The new genomics center will also serve as a showcase for the ProteomeX machines, said Grossman. These systems, which Thermo launched last March, retail for about $300,000.


Researchers throughout the Partners system, which includes Harvard Medical School, Brigham and Women's Hospital and Massachusetts General Hospital, can use the machines for clinical proteomics research.


Proteomics researchers John Yates of the Scripps Research Institute and Donald Hunt of the University of Virginia are scheduled to speak at the Partners symposium today, which will be held at the Massachusetts Institute of Technology.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.